Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALBIREO PHARMA, INC. has filed 1,239 SEC EDGAR filings since 28 Mar 2005

SEC filing history

Showing 451-475 of 938 matching filings.

Per page
25
Current page
19
8-K File 001-33451

8-K ANNUAL MEETING

Filing date
15 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SC 13G

Filing date
05 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SC 13G

Filing date
30 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

FORM 8-K

Filing date
24 May 2017
Reporting date
24 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215263

424B5

Filing date
24 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

FORM 8-K

Filing date
23 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215263

424B5

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33451

CT ORDER filing

Filing date
18 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K PHASE 3 DESIGN

Filing date
18 May 2017
Reporting date
18 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K EARNINGS RELEASE 033117

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33451

DEFA14A

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33451

DEF 14A

Filing date
21 Apr 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33451

PRE 14A

Filing date
11 Apr 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
14 Mar 2017
Reporting date
14 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
10 Feb 2017
Reporting date
07 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
27 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .